Latest Internal ribosome entry site Stories
New research has shown that a protein does something that scientists once thought impossible: It unfolds itself and refolds into a completely new shape.
According to a new analysis, even before the ribosome's many working parts were recruited for protein synthesis, proteins also were on the scene and interacting with RNA.
In the beginning – of the ribosome, the cell's protein-building workbench – there were ribonucleic acids, the molecules we call RNA that today perform a host of vital functions in cells.
A team from The Scripps Research Institute has revealed the first-ever pictures of the formation of cells' "protein factories."
CAMBRIDGE, England, November 14 /PRNewswire-FirstCall/ -- - European IRES Patent Upheld and UK Patent on Cell Screening Technology Granted - ("Stem Cell Sciences", "SCS", "the Company") IRES Patent Upheld in Appeal Hearing at the EPO Stem Cell Sciences plc (AIM:STEM, ASX:STC) announces that European patent no.
Stem Cell Sciences, a provider of stem cells and stem cell technologies, has licensed internal ribosome entry site technology to a provider of genetically modified rat and mouse models for medical and pharmaceutical research.
At the request of the Ontario Securities Commission ("OSC"), Philex Gold Inc.
A Howard Hughes Medical Institute investigator from Albany, New York, and an HHMI international research scholar from Buenos Aires, Argentina have combined their expertise to identify two peculiar features of the protein-making machinery of the parasite that causes Chagas disease. Their findings could help scientists develop a safe and effective drug for the disease, whose cardiac complications kill up to 30 percent of those infected.
- totally perplexed and mixed up.